Teva Announces Launch of $1,500,000,000 Offering of Senior Notes
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today the following private offering of senior notes: Teva…
Pharmaceuticals, Biotechnology and Life Sciences
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today the following private offering of senior notes: Teva…
Expanded Pipeline and Clinical Data Milestones Propel Company to Top Spot BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. has been named Company of…
DUBLIN–(BUSINESS WIRE)–The “US Overactive Bladder (Anticholinergics & Beta Adrenoreceptor Agonists) Market Report: Insights, Trends and Forecast (2021-2031)” report has been…
Small-volume presentation now available exclusively in FDA-approved ready-to-administer prefilled syringe LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi announced today the availability in…
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presented positive…
Statistically and clinically significant effects on pruritus, xanthomas and growth maintained for up to four years of treatment in Alagille…
— Data Demonstrate Reductions in Hepatocellular Carcinoma in Hepatitis B (HBV) Patients Treated with Vemlidy — — Improved Markers of…
AXA1665 enhances amino acid metabolism and improves ammonia disposal in subjects with mild and moderate hepatic insufficiency AXA1125 impacts key…
Pivotal trial will study the intravenous administration of the Company’s Trappsol® Cyclo™ drug and will focus on systemic and neurologic…
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced Phase 2 clinical data on a double combination of JNJ-3989 (formerly…